Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Rita E. Chen; Xianwen Zhang; James Brett Case; Emma S. Winkler; Yang Liu; Laura A. VanBlargan; Jianying Liu; John M. Errico; Xuping Xie; Naveenchandra Suryadevara; Pavlo Gilchuk; Seth J. Zost; Stephen Tahan; Lindsay Droit; Jackson S. Turner; Wooseob Kim; Aaron J. Schmitz; Mahima Thapa; David Wang; Adrianus C. M. Boon; Rachel M. Presti; Jane A. O’Halloran; Alfred H.J. Kim; Parakkal Deepak; Dora Pinto; Daved H. Fremont; James E. Crowe; Davide Corti; Herbert W. Virgin; Ali H. Ellebedy; Pei‐Yong Shi; Michael Diamond

doi:10.1038/s41591-021-01294-w

Keywords

NeutralizationPolyclonal antibodiesVirologyMonoclonal antibodyAntibodyBiologyRecombinant DNAMonoclonalCoronavirusImmune systemCoronavirus disease 2019 (COVID-19)GeneImmunologyVirusMedicineGeneticsInfectious disease (medical specialty)

Affiliated Institutions

Related Publications

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Yiska Weisblum , Fabian Schmidt , Fengwen Zhang +21 more

Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against SARS-CoV-2. Moreover, passiv...

2020 eLife 1439 citations

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Wilfredo F. García-Beltrán , Evan C. Lam , Kerri St. Denis +12 more

Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However, ongoing surveillance has revealed the emergence of variants harboring mutations in spi...

2021 Cell 1520 citations

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Thomas F. Rogers , Fangzhu Zhao , Deli Huang +31 more

Protective neutralizing antibodies Antibodies produced by survivors of coronavirus disease 2019 (COVID-19) may be leveraged to develop therapies. A first step is identifying neu...

2020 Science 1467 citations

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

Alina Baum , Benjamin O. Fulton , Elzbieta Wloga +13 more

An antibody cocktail against SARS-CoV-2 There is an urgent focus on antibodies that target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral spike and preve...

2020 Science 1445 citations

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg , Fatima Amanat , Adolfo Firpo +15 more

SARS-CoV-2 antibodies persist As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome ...

2020 Science 1241 citations

Publication Info

Year: 2021
Type: article
Volume: 27
Issue: 4
Pages: 717-726
Citations: 998
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

998

OpenAlex

Cite This

APA Style

                            
                                
                                    Rita E. Chen, 
                                
                                    Xianwen Zhang, 
                                
                                    James Brett Case
                                
                                et al.
                            
                            (2021). 
                            Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. 
                            Nature Medicine
                            , 27
                            (4)
                            , 717-726.
                            https://doi.org/10.1038/s41591-021-01294-w
                        

Identifiers

DOI: 10.1038/s41591-021-01294-w